Biosimilar

Summary : ALYMSYS® was developed by mAbxience, a global biotech company with over a decade of experience in the development, manufacture, and commercialization…

Synopsis- MS Pharma has signed an exclusive licensing and supply agreement with Bioeq AG, Switzerland to commercialize the biosimilar candidate FYB201 (Ranibizumab)…

Summary – A U.S. District Court has ruled in favor of Amgen in a patent litigation case involving the drug Enbrel, preventing…